ArticleMolecular therapy. Methods & clinical development2019

CD46 Null Packaging Cell Line Improves Measles Lentiviral Vector Production and Gene Delivery to Hematopoietic Stem and Progenitor Cells.

Stosh Ozog et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.